Concepedia

Christopher G. Willett

CG

205

Publications

37K

Citations

93

H-Index

1982

Active since

Affiliations

Massachusetts General Hospital(Current)

Duke Medical Center

The University of Texas MD Anderson Cancer Center

Harvard University

Fox Chase Cancer Center

Christopher G. Willett is an author at Massachusetts General Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1982–2025

205

Publications

205

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso et al. · Nature Medicine · 2004 · 1.9K citations · Full text

, , +9

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1.7K citations

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.6K citations · Full text

, , +14

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Alan P. Venook, Lynette Cederquist et al. · Journal of the National Comprehensive Cancer Network · 2017 · 1.4K citations · Full text

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

Joel E. Tepper, Mark J. Krasna, Donna Niedzwiecki et al. · Journal of Clinical Oncology · 2008 · 1.3K citations · Full text

Rows per page

1–5 of 205